This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogène
This LRIG1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 801-829 amino acids from the C-terminal region of human LRIG1.
Lrig1
Reactivité: Humain, Souris, Rat
WB, IF (cc), IF (p)
Hôte: Lapin
Polyclonal
Cy5
Indications d'application
For WB starting dilution is: 1:1000
Restrictions
For Research Use only
Format
Liquid
Concentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Stockage commentaire
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Antigène
Lrig1
(Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))
anticorps LIG-1, anticorps LIG1, anticorps D6Bwg0781e, anticorps Img, anticorps leucine rich repeats and immunoglobulin like domains 1, anticorps leucine-rich repeats and immunoglobulin-like domains 1, anticorps LRIG1, anticorps Lrig1
Sujet
LRIG1 act as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.